Birmingham, AL, United States of America

Albert F LoBuglio

USPTO Granted Patents = 9 

 

Average Co-Inventor Count = 4.5

ph-index = 5

Forward Citations = 58(Granted Patents)


Company Filing History:


Years Active: 2004-2024

Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: Albert F. LoBuglio: Innovator Against Cancer

Introduction

Albert F. LoBuglio, an accomplished inventor based in Birmingham, Alabama, has made significant contributions to the field of cancer research through his innovative patents. With a total of nine patents to his name, LoBuglio is dedicated to developing new methods for treating breast cancer and other malignancies, showcasing a commitment to scientific advancement and improving patient outcomes.

Latest Patents

Among his most notable inventions are two groundbreaking patents focused on cancer treatment. The first patent describes a method of treating breast cancer, which provides for and relates to novel fusion proteins and polypeptides expressed by breast cancer and other cancer cells. The methods also cover compositions and materials for detecting, characterizing, and treating these cancers. In a significant advancement, the fusion polypeptides presented are read-through fusion transcripts, highlighting his innovative approach to understanding cancer biology.

The second patent focuses on treating basal-like genotype cancers, where LoBuglio outlines methods of administering a death receptor agonist to a cancer-afflicted subject. Additionally, this invention includes methods for screening breast cancer cells for their responsiveness to a DR5 agonist and the creation of antibodies that selectively bind an N-terminal CARD of DDX3, as well as an 80 kDa baculovirus TAP repeat (BIR). These patents reflect his innovative thinking and commitment to battling cancer at a molecular level.

Career Highlights

Albert F. LoBuglio has worked with several esteemed institutions, including the UAB Research Foundation and the HudsonAlpha Institute for Biotechnology. His work in these organizations has allowed him to collaborate on significant advancements in cancer research, “translating his innovative ideas into practical applications for patient treatment.”

Collaborations

Throughout his career, LoBuglio has closely collaborated with renowned colleagues such as Donald J. Buchsbaum and Tong Zhou. These partnerships have been instrumental in pushing the boundaries of research and contributing to the development of new therapeutic strategies in oncology.

Conclusion

Albert F. LoBuglio stands as a testament to the power of innovation in the fight against cancer. His contributions through nine patents not only showcase his intellect and dedication but also offer hope for advancements in cancer treatment. With a continued focus on research and collaboration, LoBuglio's work has the potential to significantly impact the medical community and patient care in oncology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…